General Information
Version
1 / CH
Revision date
2024-09-11
Product name
Captoprilum
1.2.1 Relevant identified uses
Active pharmacutical substance
Emergency telephone
+41 (0)44 251 51 51
Icons in SDS
Company Information
company name
Hänseler AG
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H317, H360FD
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Classification of the substance or mixture
Signal word
Danger
Hazard statements
H317 May cause an allergic skin reaction. H360FD May damage fertility. May damage the unborn child.
Precautionary statements
P201 Obtain special instructions before use. P261 Avoid breathing dust/fume/gas/mist/vapours/spray. P280 Wear protective gloves/protective clothing/eye protection/face protection. P302+P352 IF ON SKIN: Wash with plenty of soap and water. P308+P313 IF expsoed or concerned: Get medicinal advice/attention. P501.3 Disposal in compliance with local and national regulations.
Contains
Captopril
Additional information
Further supplemental information Restricted to professional users
Further information
Not for supply to the general public in Switzerland
2.3 Other hazards
The Substance does not meet PBT-criteria. This substance does not meet the vPvB-criteria. This substance does not have endocrine disrupting properties with respect to humans. This substance does not have endocrine disrupting properties with respect to non-target organisms.
2.1 Classification of the substance or mixture
Classification (Regulation (EC) No. 1272/2008) Skin Sens. 1 H317 Repr. 1A H360FD The product is classified and labelled in accordance with Regulation (EC) No 1272/2008 For explanation of abbreviations see section 16. 2.2. Label elements
